Keros Therapeutics Inc. (KROS)
NASDAQ: KROS
· Real-Time Price · USD
16.05
0.25 (1.58%)
At close: Sep 26, 2025, 3:59 PM
15.76
-1.81%
After-hours: Sep 26, 2025, 05:32 PM EDT
Keros Therapeutics Revenue
Keros Therapeutics reported an annual revenue of $3.55M, reflecting a 2250.99% growth. For the quarter ending June 30, 2025, Keros Therapeutics generated $18.17M in revenue.
Revenue (ttm)
3.55M
Revenue Growth
2250.99%
Price / Sales Ratio
166.94
Revenue / Employee
21.78K
Employees
163
Market Cap
651.88M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 3.55M | +2250.99% |
| Dec 31, 2023 | 151K | +Infinity% |
| Dec 31, 2022 | 0 | -100.00% |
| Dec 31, 2021 | 20.1M | +Infinity% |
| Dec 31, 2020 | 0 | -100.00% |
| Dec 31, 2019 | 10M | n/a |
| Dec 31, 2018 | 10M | n/a |